13C-butyrate breath test
Diagnostic Testbreath test
NCT Number: NCT05735002
CMI is an incapacitating disease and timely diagnosis remains problematic. Despite the substantial compensatory capacity of the mesenteric circulation CMI is relatively common, its incidence being comparable to other well-known diseases like Crohn's disease.
Diagnostic tools are needed for two purposes since the exclusion of CMI currently requires a cumbersome complication-prone diagnostic workup and since a definitive diagnosis is mainly established per exclusionem. First, a sensitive test is desirable to rule out CMI and avoid excessive diagnostic investigations. Quantification of mesenteric arterial calcification on computed tomography (CT) seems suitable for this purpose, synonymous with the coronary artery calcium score. Second, a specific test is required confirming CMI by detection of mucosal ischemia during a meal, when oxygen demand peaks. A breath test, based on the requirement of oxygen to absorb and metabolize 13C-butyrate in the enterocyte, could detect mucosal ischemia
Objective: Facilitating diagnosis of chronic mesenteric ischemia (CMI) using 1) the mesenteric artery calcium score (MACS) and 2) mucosal ischemia detection by butyrate breath testing
Study design: Multicentre prospective cohort studies.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Medisch Spectrum Twente, Enschede, Overijssel, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
breath test
Time frame: 2023-2025
Time frame: 2023-2035
To validate the mesenteric artery calcium score as a readily available, easy, and sensitive test with a high negative predictive value to either rule out CMI or select patients for further investigations.
Contact information is provided by the study sponsor or research team.
Desirée Leemreis - van Noord, MD, PhD
CONTACT
Eva Karina Bocharewicz, MD, PhD Candidate
CONTACT
Erasmus Medical Center
Other
PRomoting Early Diagnosis Of Chronic Mesenteric ISchEmia by a Mesenteric Artery Calcium Score Based Risk Stratification and Detection of Postprandial Mucosal Ischemia by Butyrate Breath Testing
Acronym: PROMISE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07059520
Cardiovascular Diseases, Chronic Mesenteric Ischemia
Enschede, Overijssel, Netherlands
View Trial DetailsNCT06468774
Arterial Occlusive Diseases, Biliary Tract Diseases
Oslo, Norway
View Trial DetailsNCT02914912
Chronic Mesenteric Ischemia
Oslo, Norway
View Trial DetailsNCT07182669
Chronic Mesenteric Ischemia
Copenhagen, State, Denmark
View Trial Details